Meningococcal Disease Completed Phase 4 Trials for Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)

IndicationStatusPhase
DBCOND0033309 (Meningococcal Disease)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01896596Hepatitis B Vaccination in InfantsPrevention